Wegovy generic names: what the medicine is actually called, and why it matters

The decision hiding inside a generic-name search

Most people who search for Wegovy's generic name are really asking one of two things: is there a cheaper version available, or is semaglutide the same as something else their doctor mentioned? Both are completely reasonable questions, and if you want the full picture on what Wegovy's generic name actually means in practice, that detail is worth reading before going further. The honest answer to the first is no, there is no unbranded, generic-licensed semaglutide product on the UK market right now. Patent protection means the only legal route to semaglutide for weight loss is through Novo Nordisk's branded products: Wegovy injection or, since June 2026, Wegovy tablets. The question of whether semaglutide is the same molecule under another name, however, is worth a more careful answer, because it shapes which product a prescriber can lawfully offer you and for what.

Understanding the distinction isn't just a naming technicality. It affects your eligibility, the dose you'd receive, and the clinical goal the treatment is being used to achieve. If you'd like to see how semaglutide compares to the other licensed weight-loss medicine available in the UK, the weight-loss treatments overview sets this out clearly.

Wegovy, Ozempic and Rybelsus: same molecule, different licences

Semaglutide was originally developed for type 2 diabetes. Ozempic (the weekly injection) and Rybelsus (the daily oral tablet) are both licensed in the UK for blood-sugar management in adults with type 2 diabetes, not for weight loss. The relationship between Wegovy and its branded siblings confuses a lot of people, and understandably so, because the molecule is identical. What differs is the dose, the indication, and therefore the licence.

Wegovy injections run from 0.25 mg up to 2.4 mg weekly (with a newly approved 7.2 mg pen for eligible patients), and are specifically indicated for weight management. Ozempic tops out at 2 mg weekly and is prescribed for glycaemic control. Rybelsus tablets come in 3 mg, 7 mg and 14 mg strengths for diabetes. The Wegovy tablet, approved this summer, escalates through 1.5 mg, 4 mg and 9 mg to a 25 mg daily maintenance dose, strengths and steps that are entirely separate from the Rybelsus diabetes ladder. A prescriber cannot swap one for another without changing the indication entirely, and it would not be clinically appropriate to do so. The NHS medicines information page for semaglutide sets out the distinction in patient-friendly terms worth bookmarking.

Will a generic version of semaglutide become available in the UK?

This is the question many people are really arriving at. Patent timelines for pharmaceutical products are complex and can shift, so a precise date is impossible to give. What can be said clearly is that as of summer 2026, understanding what a semaglutide generic would actually involve helps explain why none is yet licensed for weight management in the UK, and none has received MHRA approval. If and when that changes, any generic would still need to meet the same regulatory standard for safety and efficacy as the original, and would still require a valid prescription following a clinical assessment. The question of when semaglutide might go generic is covered in more detail on a dedicated page.

It's worth being clear about one more thing: unlicensed or compounded semaglutide products that have appeared online are not the same as a properly approved generic. The MHRA has issued repeated warnings about counterfeit and unlicensed weight-loss pens sold via social media and unverified websites. Products offered without a formal clinical assessment and a valid prescription from a GPhC-registered pharmacy carry real risk. If you're unsure whether a pharmacy is legitimate, the GPhC pharmacy register lets you check its registration in seconds. You can verify our own pharmacy there under registration number 9012878.

What this means if you're considering treatment now

The practical upshot is straightforward. If semaglutide for weight loss is what you're looking for, Wegovy (injection or tablet) is the only licensed option in the UK. There is no cheaper branded equivalent, no approved generic, and no shortcut that sidesteps a prescription. That's not a commercial argument; it's the regulatory position.

What that prescription process looks like matters. At nume, a GPhC-registered Independent Prescriber reads your consultation personally, your answers don't go to an algorithm. If approved, treatment is dispatched the same day for free next-working-day delivery. For context on what private semaglutide treatment typically costs and what an all-in price should include, the guide to where to buy Wegovy in the UK covers the landscape honestly. The clinical team behind our consultations is introduced on the clinical team page, and when you're ready, the straightforward next step is to start your free consultation.